Oncology Therapeutics
Roivant news and milestones
Roivant: 6 headlines on record, 6 headlines in the last 90 days. Its story counts 2 milestones.
Data updated Nov 16, 2026 · Back to the company report
6Headlines
6In 90 days
2Milestones
Headlines
Sep 222026
Sep 102026
News · STAT
The recent success of the company's lung disease drug in a mid-stage study is a testament to its sharp approach.
Sep 92026
News · Pulse 2.0
Roivant Sciences announced positive results from the Phase 2 PHocus study of mosliciguat in patients with pulmonary hypertension associated with interstitial lung disease, or PH-…
Sep 82026
News · seekingalpha.com
Sep 82026
News · fiercebiotech.com
Aug 282026
News · markets.businessinsider.com
LISRAYA represents the first major therapeutic innovation in decades for adults with dermatomyositis (DM), a debilitating systemic autoimmune dise...
Sources: the outlets named on each headline, each story once
Milestones
2014
Founded
Each milestone is dated by its source: registers, filings, the press
How to cite
Roivant, News. Alion, Nov 16, 2026. https://alion.io/company/roivant/news
